247 related articles for article (PubMed ID: 14535265)
1. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Oct; 68(194):57799-804. PubMed ID: 14535265
[TBL] [Abstract][Full Text] [Related]
2. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
[TBL] [Abstract][Full Text] [Related]
3. Self-certification and employee training of mail-order distributors of scheduled listed chemical products. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2011 Apr; 76(71):20518-24. PubMed ID: 21491808
[TBL] [Abstract][Full Text] [Related]
4. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2010 Jul; 75(129):38915-22. PubMed ID: 20608288
[TBL] [Abstract][Full Text] [Related]
5. Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Feb; 75(20):4973-82. PubMed ID: 20352663
[TBL] [Abstract][Full Text] [Related]
6. Import and production quotas for certain List I chemicals. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Jul; 72(131):37439-53. PubMed ID: 17674492
[TBL] [Abstract][Full Text] [Related]
7. Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2006 Sep; 71(186):56008-27. PubMed ID: 17017470
[TBL] [Abstract][Full Text] [Related]
8. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
[TBL] [Abstract][Full Text] [Related]
9. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
[TBL] [Abstract][Full Text] [Related]
10. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
[TBL] [Abstract][Full Text] [Related]
11. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
[TBL] [Abstract][Full Text] [Related]
12. Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2001 Aug; 66(159):42944-6. PubMed ID: 11757558
[TBL] [Abstract][Full Text] [Related]
13. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
[TBL] [Abstract][Full Text] [Related]
14. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
[TBL] [Abstract][Full Text] [Related]
15. Changes in the regulation of iodine crystals and chemical mixtures containing over 2.2 percent iodine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Jul; 72(126):35920-31. PubMed ID: 17910137
[TBL] [Abstract][Full Text] [Related]
16. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
[TBL] [Abstract][Full Text] [Related]
17. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(35):8105-7. PubMed ID: 14997866
[TBL] [Abstract][Full Text] [Related]
18. Recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB). Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2005 Jan; 70(2):291-4. PubMed ID: 15630794
[TBL] [Abstract][Full Text] [Related]
19. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
[TBL] [Abstract][Full Text] [Related]
20. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
